Cystatin C-NT-proBNP Combined Risk Score Calculator
Biomarker inputs
Enter both laboratory values to view a descriptive, threshold-based summary.
Clinical context
Cystatin C is a marker used to assess kidney function and can provide prognostic information in cardiovascular disease. Its interpretation depends on the assay, kidney function, and the patient population.
NT-proBNP is released in response to myocardial wall stress and is used in the evaluation of suspected heart failure and in prognostic assessment. Values are influenced by factors including age and renal function, and must be interpreted in clinical context.
Studies support the complementary prognostic value of kidney-function measures and natriuretic peptides in selected heart-failure populations. That evidence does not, by itself, validate the simple two-threshold score shown here.
Thresholds retained from the source code
| Marker | Threshold used by this tool | Evidence status |
|---|---|---|
| Cystatin C | ≥ 1.0 mg/L | Retained from the original PHP; not verified as a universal or model-specific cutoff. |
| NT-proBNP | ≥ 125 pg/mL | A threshold used in some contexts to identify elevated NT-proBNP, but not verified as part of this exact combined score. |
How to use the result
- Review both biomarker values separately alongside symptoms, examination, kidney function, age, and the clinical indication for testing.
- Do not interpret the marker count as an absolute or relative probability of death, heart failure, or another cardiovascular outcome.
- Use a validated clinical prediction model or the relevant guideline pathway when a formal risk estimate is needed.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.